clvs

Clovis Oncology Inc. (NASDAQ: CLVS)Shares Spiked After Positive Phase 3 Data

Clovis Oncology Inc. (NASDAQ: CLVS)Shares Spiked After Positive Phase 3 Data

Clovis Oncology Inc. (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. The company’s shares jumped ab..